[
  {
    "ts": null,
    "headline": "Viatris (VTRS) Faces Securities Fraud Class Action Over FDA Inspection Fallout",
    "summary": "On May 31, 2025, Viatris Inc. (NASDAQ:VTRS) became the subject of a securities fraud class action lawsuit filed in the U.S. District Court for the Western District of Pennsylvania. The suit alleges that between August 8, 2024, and February 26, 2025, the company and certain executives made materially false or misleading statements regarding the operational […]",
    "url": "https://finnhub.io/api/news?id=f9c307fd1dfe861c4146a08e507fbf10b90734831882ef7f01ede8e8a6489ffb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749233080,
      "headline": "Viatris (VTRS) Faces Securities Fraud Class Action Over FDA Inspection Fallout",
      "id": 135086267,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "On May 31, 2025, Viatris Inc. (NASDAQ:VTRS) became the subject of a securities fraud class action lawsuit filed in the U.S. District Court for the Western District of Pennsylvania. The suit alleges that between August 8, 2024, and February 26, 2025, the company and certain executives made materially false or misleading statements regarding the operational […]",
      "url": "https://finnhub.io/api/news?id=f9c307fd1dfe861c4146a08e507fbf10b90734831882ef7f01ede8e8a6489ffb"
    }
  }
]